Knotless Barbed Suture Closure of the Uterus at Caesarean Section
1 other identifier
observational
957
1 country
1
Brief Summary
Caesarean section (CS) is an increasingly common mode of delivery. The way in which this operation is carried out is important as it affects millions of women each. In recent years use of a 'self-retaining' suture or thread for closure of the uterine closure has become a recognised approach with a proven safety record. These sutures are known as knotless barbed sutures (KBS) as the unidirectional barbs on the surface of the suture hold the suture in the tissue without the need for knots. These sutures can be used instead of the usual 'smooth' suture which requires knots at the angles. There are high-level level data that CS are quicker and on average need fewer additional stitches to control blood loss when KBS are used. There is additional evidence of a potential reduction in problems with healing of the uterus with KBS, it is thought that this might lead to a lower risk of problems in repeat CS as the chance of the placenta implanting into the scar might be lower. At present this evidence is based on ultrasound surveillance of scar appearance which is an indirect measure. The real risk difference will need to be explored with the examination of real world outcomes over the coming years. There is currently no published data on KBS for uterine closure at caesarean from the UK. This cohort, although retrospective, is adequately controlled, shows excellent outcomes and signals a potential marked reduction in infectious morbidity. This potentially means a better patient experience as well as a large cost saving because of reduced re-admission rates. These data were collected as part of a service improvement project but the generalisable nature of our findings mean the finding are research and should be published.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 11, 2025
CompletedFirst Submitted
Initial submission to the registry
May 13, 2025
CompletedFirst Posted
Study publicly available on registry
May 20, 2025
CompletedMay 29, 2025
January 1, 2025
2.3 years
May 13, 2025
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative infection
Whether antibiotics were prescribed for a surgical site infective complication.
up to 6 weeks post-operative
Secondary Outcomes (4)
operating time
Intraoperative
Blood loss
In theatre during the operation
Readmission
up to 6 weeks post-operative
Re-attendance as an outpatient
up to 6 weeks post-operative
Other Outcomes (1)
Operative complications
Intraoperative and up to 6 weeks post-operatively
Study Arms (6)
Group 1 (Elective Caesareans undertaken using knotless barbed suture)
Elective caesareans undertaken using knotless barbed sutures. This included all cases without exception on the CI's regular operating list from January 2023 (after a positive trial period which resulted in this becoming the standard for the CI). n290.
Group 2 (Elective caesarean sections on a number of consultant lists using standard sutures SS)
May-August 2024 all cases on the respective lists n215
Group 3 (Emergency caesarean deliveries when KBS was used for closure of the hysterotomy)
Emergency caesarean deliveries (category 1-3 urgency - all except elective) using KBS January 2023-December 2024. n 107.
Group 4 (Emergency caesarean deliveries employing Standard sutures for closure of the hysterotomy)
All non-cat 4 CS using SS (May-August 2024) n 345
Group 5 (comprising all cases in group 1 and group 3)
All the KBS caesarean deliveries n 397
Group 6 (comprising group 2 and group 4)
All the SS cases n560
Interventions
Use of Medtronic V-loc 180 suture (VL) for a 2 layer closure of the caesarean hysterotomy rather than the standard 2 layer closure using the 910 polyglactin suture (SS).
Standard 2 layer closure using the 910 polyglactin suture (SS)
Eligibility Criteria
Women having a caesarean section at James Cook University Hospital within the study period
You may qualify if:
- Women undergoing a caesarean section at the study hospital within the data collection period for that cohort - either with or without KBS depending on the cohort.
You may not qualify if:
- Not falling within the search criteria for a comparator group
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
James Cook University Hospital
Middlesbrough, TS43BW, United Kingdom
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2025
First Posted
May 20, 2025
Study Start
November 1, 2022
Primary Completion
February 11, 2025
Study Completion
February 11, 2025
Last Updated
May 29, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Feb 2025
- Access Criteria
- Open access on CT.gov
IPD will be shared via CT.gov on an excel spreadsheet without identifiable information being provided